β-amyloid increases cathepsin D levels in hippocampus

Neuroscience Letters

Volumn 250, Issue 2, 1998, Pages 75-78

  Hoffman, Keith B ^a   Bi, Xiaoning ^a   Pham, Jane T ^a   Lynch, Gary ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid; Cathepsin D; Hippocampus; Lysosomes

Indexed keywords

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; HIPPOCAMPUS; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CATHEPSIN D; CULTURE TECHNIQUES; HIPPOCAMPUS; HUMANS; LYSOSOMES; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0344505216     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00364-4     Document Type: Article

References (29)

1. Bahr B.A., Abai B., Gall C.M., Vanderklish P.W., Hoffman K.B., Lynch G. Induction of β-amyloid containing polypeptides in hippocampus: evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp. Neurol. 129:1994;1-14.
2. Bahr B.A., Kessler M., Rivera S., Vanderklish P.W., Hall R.A., Mutneja M.S., Gall C., Hoffman K.B. Stable maintenance of glutamate receptors and other synaptic components in long-term hippocampal slices. Hippocampus. 5:1995;425-439.
3. Bahr, B.A., Hoffman, K.B., Yang, A.J., Hess, U.S., Glabe, C.G. and Lynch, G., Amyloid β-protein is selectively internalized by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein, J. Comp. Neurol. (1998) in press.
4. Bednarski E., Lynch G. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J. Neurochem. 67:1996;1846-1855.
5. Bednarski E., Ribak C.E., Lynch G. Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus. J. Neurosci. 17:1997;4006-4021.
6. Braak, H. and Braak, E., (Eds.), Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with aging and Alzheimer's disease. In Progress in Brain Research, Elsevier Science, New York, 1986.
7. Burdick D., Kosmoski J., Knauer M.F., Glabe C.G. Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1-42, in differentiated PC12 cells. Brain Res. 746:1997;275-284.
8. Caporaso G.L., Gandy S.E., Buxbaum J.D., Greengard P. Chloroquine inhibits intracellular degradation but not secretion of Alzheimer beta/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA. 89:1992;2252-2256.
9. Cataldo A.M., Nixon R.A. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc. Natl. Acad. Sci. USA. 87:1990;3861-3865.
10. Cataldo A.M., Thayer C.Y., Bird E.D., Wheelock T.R., Nixon R.A. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res. 513:1990;181-192.
11. Cataldo A.M., Barnett J.L., Mann D.M., Nixon R.A. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome. J. Neuropathol. Exp. Neurol. 55:1996;704-715.
12. Cataldo A.M., Hamilton D.J., Barnett J.L., Paskevich P.A., Nixon R.A. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16:1996;186-199.
13. Golde T.E., Estus S., Younkin L.H., Selkoe D.J., Younkin S.G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science. 255:1992;728-730.
14. Green G.D., Shaw E. Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. J. Biol. Chem. 256:1981;1923-1928.
15. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., Selkoe D.J. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
16. Ivleva T.S., Ogloblina T.A., Litinskaya L.L., Ya Wiederschain G. Estimation and comparison of lysosomal and cytoplasmic pH of human fibroblasts from healthy donors and patients with lysosomal storage diseases. Biomed. Sci. 2:1991;398-402.
17. Ivy G., Shottler F., Wenzel J., Baudry M., Lynch G. Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. Science. 226:1984;985-987.
18. Ivy G., Kitani K., Ihara Y. Anomalous accumulation of tau and ubiquitin immunoreactivities in rat brain caused by protease inhibition and by normal aging: a clue to PHF pathogenesis? Brain Res. 489:1989;360-365.
19. Knauer M.F., Soreghan B., Burdick D., Kosmoski J., Glabe C.G. Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. USA. 89:1992;7437-7441.
20. Kenessey A., Banay-Schwartz M., De Guzman T., Lajtha A. Increase in cathepsin D activity in rat brain in aging. J. Neurosci. Res. 23:1989;454-456.
21. Kohnken R.E., Ladror U.S., Wang G.T., Holzman T.F., Miller B.E., Krafft G.A. Cathepsin D from Alzheimer's-diseased and normal brains. Exp. Neurol. 133:1995;105-112.
22. Ladror U.S., Snyder S.W., Wang G.T., Holzman T.F., Krafft G.A. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J. Biol. Chem. 269:1994;18422-18428.
23. Nakamura Y., Takeda M., Suzuki H., Morita H., Tada K., Hariguchi S., Nishimura R. Lysosome instability in aged rat brain. Neurosci. Lett. 97:1989;215-220.
24. Nakanishi H., Tominaga K., Amano T., Hirotsu I., Inoue T., Yamamoto K. Age-related changes in activities and localizations of cathepsin D, E, B and L in the rat brain tissues. Exp. Neurol. 126:1994;119-128.
25. Ohkuma, S., The lysosomal proton pump and its effect on protein breakdown. In H. Glaumann and F.J. Ballard (Eds.), Lysosomes: Their role in Protein Breakdown, Academic Press, London, 1987, pp. 115-148.
26. Pliura D.H., Bonaventura B.J., Smith R.A., Coles P.J., Krantz A. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases. Biochem. J. 288:1992;759-762.
27. Schwagerl A.L., Mohan P.S., Cataldo A.M., Vonsattel J.P., Kowall N.W., Nixon R.A. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J. Neurochem. 64:1995;443-446.
28. Siman R., Mistretta S., Durkin J.T., Savage M.J., Loh T., Trusko S., Scott R.W. Processing of the beta-amyloid precursor. Multiple proteases generate and degrade potentially amyloidogenic fragments. J. Biol. Chem. 268:1993;16602-16609.
29. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37:1991;173-182.